@vtnntamthanhphat: ๐†๐ข๐จฬ‰ ๐ก๐šฬ€๐ง๐  ๐œ๐ฎฬ‰๐š ๐ž๐ฆ ๐จฬ›ฬ‰ ๐ ๐จฬ๐œ ๐ญ๐ซ๐šฬ๐ข ๐ฆ๐šฬ€๐ง ๐ก๐ขฬ€๐ง๐ก ๐ช๐ฎ๐ฒฬ ๐š๐ง๐ก ๐œ๐ก๐ขฬฃ ๐›๐šฬ‚ฬ๐ฆ ๐ฏ๐šฬ€๐จ ฤ‘๐žฬ‚ฬ‰ ๐ฆ๐ฎ๐š ๐ง๐ก๐š. ๐๐žฬ‚ฬ๐ฎ ๐ค๐ก๐จฬ‚๐ง๐  ๐ญ๐ก๐šฬ‚ฬ๐ฒ ๐ ๐ข๐จฬ‰ ๐ก๐šฬ€๐ง๐  ๐ช๐ฎ๐ฒฬ ๐š๐ง๐ก ๐œ๐ก๐ขฬฃ ๐›๐šฬ‚ฬ๐ฆ ๐ฏ๐šฬ€๐จ ๐ญ๐ซ๐š๐ง๐  ๐œ๐šฬ ๐ง๐ก๐šฬ‚๐ง ๐“๐ข๐ค๐“๐จ๐ค ๐œ๐ฎฬ‰๐š ๐ž๐ฆ ฤ‘๐žฬ‚ฬ‰ ๐ž๐ฆ ๐ง๐ก๐š.

VTNN Tรขm Thร nh Phรกt
VTNN Tรขm Thร nh Phรกt
Open In TikTok:
Region: VN
Thursday 29 October 2026 06:21:18 GMT
97
1
0
0

Music

Download

Comments

There are no more comments for this video.
To see more videos from user @vtnntamthanhphat, please go to the Tikwm homepage.

Other Videos

Bill Ackman's hedge fund lost nearly $4 billion on a single investment. His reputation collapsed, investors pulled money from his firm, and his marriage ended during one of the most difficult periods of his career. Then he returned with two extraordinary years of investment performance. Ackman was already one of Wall Street's most recognizable investors. Through Pershing Square Capital Management, he had built a reputation for making enormous bets on companies he believed were undervalued or poorly managed. But his investment in Valeant Pharmaceuticals became a financial disaster. Pershing Square began investing in Valeant in 2015. Ackman believed the pharmaceutical company's acquisition-driven business model could produce substantial returns. For a while, the investment looked promising. Valeant shares climbed above $260 in 2015, making the company one of Wall Street's most closely watched businesses. Then everything began unraveling. Valeant faced intense scrutiny over its pricing practices, accounting, and pharmaceutical distribution relationships. Its shares plunged as investors questioned the sustainability of its business. Ackman continued supporting the company, even joining its board and helping push for management changes. But the decline continued. By March 2017, Pershing Square had abandoned the investment. The total damage reached approximately $4 billion, according to contemporary financial reporting. Ackman publicly apologized to his investors and described the investment as a huge mistake. The financial disaster wasn't his only problem. His firm faced shareholder litigation connected to a separate takeover attempt involving Allergan. Pershing Square and Valeant eventually agreed to a $290 million settlement, with Pershing Square responsible for approximately $194 million. During this turbulent period, Ackman also went through a divorce. His investment firm suffered four consecutive years of negative returns from 2015 through 2018. Investors withdrew billions, and his reputation as one of Wall Street's most successful hedge fund managers took a serious hit. But Ackman didn't shut down Pershing Square. He reduced outside capital, refocused the investment strategy, and concentrated on a smaller portfolio of businesses. Then the numbers changed dramatically. Pershing Square generated a 58.1% net investment return in 2019. In 2020, it delivered another 70.2%. Those were investment returns, not increases in Ackman's personal wealth, but they represented an extraordinary reversal for a firm that had spent years struggling. Pershing Square went on to generate a further 26.9% return in 2021. The investor whose firm had lost nearly $4 billion on Valeant had rebuilt its performance through a new series of successful investment decisions. His earlier losses were never erased from the record. Neither were the lawsuits, withdrawals, or years of underperformance. But the same hedge fund that had endured four consecutive losing years subsequently delivered two annual returns above 50%.
Bill Ackman's hedge fund lost nearly $4 billion on a single investment. His reputation collapsed, investors pulled money from his firm, and his marriage ended during one of the most difficult periods of his career. Then he returned with two extraordinary years of investment performance. Ackman was already one of Wall Street's most recognizable investors. Through Pershing Square Capital Management, he had built a reputation for making enormous bets on companies he believed were undervalued or poorly managed. But his investment in Valeant Pharmaceuticals became a financial disaster. Pershing Square began investing in Valeant in 2015. Ackman believed the pharmaceutical company's acquisition-driven business model could produce substantial returns. For a while, the investment looked promising. Valeant shares climbed above $260 in 2015, making the company one of Wall Street's most closely watched businesses. Then everything began unraveling. Valeant faced intense scrutiny over its pricing practices, accounting, and pharmaceutical distribution relationships. Its shares plunged as investors questioned the sustainability of its business. Ackman continued supporting the company, even joining its board and helping push for management changes. But the decline continued. By March 2017, Pershing Square had abandoned the investment. The total damage reached approximately $4 billion, according to contemporary financial reporting. Ackman publicly apologized to his investors and described the investment as a huge mistake. The financial disaster wasn't his only problem. His firm faced shareholder litigation connected to a separate takeover attempt involving Allergan. Pershing Square and Valeant eventually agreed to a $290 million settlement, with Pershing Square responsible for approximately $194 million. During this turbulent period, Ackman also went through a divorce. His investment firm suffered four consecutive years of negative returns from 2015 through 2018. Investors withdrew billions, and his reputation as one of Wall Street's most successful hedge fund managers took a serious hit. But Ackman didn't shut down Pershing Square. He reduced outside capital, refocused the investment strategy, and concentrated on a smaller portfolio of businesses. Then the numbers changed dramatically. Pershing Square generated a 58.1% net investment return in 2019. In 2020, it delivered another 70.2%. Those were investment returns, not increases in Ackman's personal wealth, but they represented an extraordinary reversal for a firm that had spent years struggling. Pershing Square went on to generate a further 26.9% return in 2021. The investor whose firm had lost nearly $4 billion on Valeant had rebuilt its performance through a new series of successful investment decisions. His earlier losses were never erased from the record. Neither were the lawsuits, withdrawals, or years of underperformance. But the same hedge fund that had endured four consecutive losing years subsequently delivered two annual returns above 50%.

About